These findings, in combination with our scRNA-seq data from the bone marrow of B-ALL patients, suggest that transcription factor-KLF2 decreases the proliferation of NK cells and impairs their ability to eliminate B-ALL. The gene discussed is KLF2; the disease is precursor B-cell acute lymphoblastic leukemia.